SEC Filing Summary: Alphabet Inc. Form 13F
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. for the reporting period ending June 30, 2026. The document discloses Alphabet's equity holdings in other public companies as of the close of the second quarter of 2026. It does not contain Alphabet's own financial performance data (revenue, profit, or cash flow).
Key Financial Metrics and Portfolio Composition
The filing details Alphabet's investment portfolio, categorized by voting authority (Sole, Shared, or None). Key portfolio metrics include:
- Total Disclosed Positions: 30 distinct equity positions listed.
- Largest Position by Value: Space Exploration Technologies Corp (SpaceX) with a reported value of approximately $94.18 billion (551,189,500 shares).
- Second Largest Position by Value: Planet Labs PBC with a reported value of approximately $1.17 billion (35,248,893 shares).
- Third Largest Position by Value: Revolution Medicines Inc with a reported value of approximately $551.84 million (2,946,619 shares).
- Notable Tech Holdings: Significant positions in Arm Holdings PLC (~$695M), CME Group Inc (~$769M), UiPath Inc (~$76M), and Figma Inc (~$3.9M).
- Biotech/Healthcare Exposure: Substantial holdings in companies such as Prime Medicine Inc (~$61M), Parabilis Medicines Inc (~$135M), and Maze Therapeutics Inc (~$41M).
Material Changes Versus Prior Period
Not Applicable. This filing text provides a snapshot of holdings as of June 30, 2026. It does not include comparative data from the prior quarter (March 31, 2026) or year-over-year changes. Therefore, material changes in position size cannot be determined from this document alone.
Guidance, Outlook, and Risks
Not Applicable. Form 13F filings are regulatory disclosures of holdings and do not contain management commentary, forward-looking guidance, risk factors, or contingency plans regarding Alphabet's own operations. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy.
Investor Verification Checklist
- SpaceX Valuation: Verify the reported value of $94.18 billion for Space Exploration Technologies Corp, as this represents a significant portion of the disclosed portfolio and may reflect a private-to-public transition or specific valuation methodology.
- Voting Authority: Note that most positions are held with "Sole" discretion, but some (e.g., Arm Holdings, CME Group, Planet Labs) are marked with "Shared" or "None" voting authority, which may indicate different investment vehicles or fund structures.
- Portfolio Concentration: Assess the concentration risk given the massive valuation assigned to the SpaceX position relative to other holdings.
- Missing Data: Confirm if this is a complete filing or a partial update, as the total aggregate value of the portfolio is not explicitly summed in the text provided.